General Announcement::FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Sep-2026 06:30:36
Status
New
Announcement Sub Title
FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging
Announcement Reference
SG260930OTHRZ6TZ
Submitted By (Co./ Ind. Name)
Ida Lawrance
Designation
Head of Corporate Governance
Effective Date and Time of the event
30/09/2026 17:00:00
Description (Please provide a detailed description of the event in the box below)
FDA Fast Track designation granted for Telix's BiPASS program

Attachments

30Sept2026 Telix granted FDA Fast Track Designation for BiPASS.pdf
Total size =185K